Skip to content

Study, 2024

How does PMDD affect women's daily lives?

Women with PMDD report that their symptoms severely disrupt relationships, work, education, and self-image during the premenstrual phase. Healthcare providers often lack understanding of the condition.

Early or limited evidence 15 women in the UK with PMDD

What they did

The study recruited 15 women from a UK PMDD patient group and screened them using a questionnaire. Researchers conducted individual interviews with each woman on Zoom, transcribed the recordings, and analyzed them to find common themes.

What they found

The analysis identified 4 main themes: the overwhelming nature of symptoms during the cycle, the impact on daily life, how women cope, and experiences with healthcare. Symptoms appear during the premenstrual phase and disappear when menstruation begins, severely affecting relationships, careers, education, and sense of self.

What it means for you

This study shows that PMDD causes serious disruption to women's lives and that healthcare providers often lack understanding. The main limitation is that only women in the UK were interviewed, so findings may not apply to other countries.

15

women interviewed

4

main themes identified

About the study

Original title
The Emotional Experiences of Women Suffering From Premenstrual Dysphoric Disorder in the United Kingdom
Authors
Al-Hassan N, Hockham C, Matthews L et al.
Journal
BJPsych open
Year
2024
Study design
Study
What was tested
None - this is a qualitative observational study
Open access
Yes
Original abstract

Aims 1) To hear directly from women suffering from PMDD about their lived experiences of PMDD and the impacts that it has on their daily lives. 2) To raise awareness about the impacts that PMDD can have on patients' quality of life, relationships, and productivity, to improve clinicians’ understanding of patients' needs. 3) To identify a gap in research into PMDD within the UK and highlight the need for further research. 4) To improve awareness of PMDD amongst diverse stakeholders, including women who are not yet diagnosed with PMDD, employers, and policymakers. Methods Participants were recruited from the UK's PMDD Patient Insight Group and screened using the Premenstrual Symptom Screening Tool (PSST) for PMDD. Eligible participants were purposively sampled, and 15 participants were invited to a semi-structured scheduled interview on Zoom. Interviews were transcribed using NVivo transcription software, and inductively analyzed using reflexive thematic analysis in NVivo 14. Results Thirteen subthemes were identified and organised around four main themes: Theme 1: ‘Jekyll and Hyde’, Life with PMDD, Theme 2: ‘The Aftermath’, The Impact of Living with PMDD, Theme 3: ‘Surviving PMDD’, Coping Strategies, and Theme 4: ‘Seeking Treatment’, Experiences with Healthcare. The themes identified in this study highlight the negative experiences of women living with debilitating symptoms that appear during the luteal phase and disappear following the onset of menstruation. Themes also capture the immense burden PMDD places on a sufferer by uncovering how exactly these symptoms affect interpersonal relationships, career progression, quality of education received, and relationship with oneself. Theme 4 focuses on women's negative experiences with healthcare stemming from a lack of awareness of PMDD in the medical community. Conclusion The findings of this study highlight the critical importance of understanding the contextualized experiences of women living with PMDD in the UK and bringing to light the immense monthly burden sufferers face. To prevent women and Assigned Female At Birth (AFAB) individuals from experiencing severe and prolonged psychological distress which can have fatal consequences, there needs to be greater understanding and awareness of PMDD in both medical and lay communities. In addition to this, clinicians must be trained in PMDD assessment and research should be encouraged to introduce new treatments and to implement policies that minimize the burden of PMDD in the workplace.

Reproduced under CC-BY.

Topics